Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
12/2005
12/22/2005US20050281810 Variants of alternative splicing
12/21/2005EP1606417A2 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna
12/21/2005EP1606399A2 Method of screening for target ligands
12/21/2005EP1606396A2 Methods of promoting the differentiation of stem cells
12/21/2005EP1606389A2 Compositions and methods for polynucleotide sequence detection
12/21/2005EP1606386A2 Removal of plastid sequences by transiently expressed site-specific recombinases
12/21/2005EP1606304A2 Nucleotide sequences regulating gene expression and constructs and methods utilizing same
12/21/2005EP1606302A2 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
12/21/2005EP1605960A2 Use of secretin and secretin analogs to treat affective disorders
12/21/2005EP1534865A4 Methods and compositions for determining methylation profiles
12/21/2005CN1232644C Optimization method for activation of endogenetic gene of cell
12/15/2005WO2005118808A1 Nucleic acid molecules as heparanase potent inhibitors, compositions and methods of use thereof
12/15/2005WO2005059100A3 Methods and compositions relating to cystatin c
12/15/2005WO2005033267A3 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof
12/15/2005WO2005023993A3 Methods and compositions for generation of germline human antibody genes
12/15/2005WO2005017124A3 Peptide deformylase inhibitors
12/15/2005WO2005007832A3 System for external control of oncolytic virus replication
12/15/2005WO2005005610A3 Mutant adeno-associated virus virions and methods of use thereof
12/15/2005WO2004104162A3 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
12/15/2005WO2004101764A3 Methods of modulating metastasis and skeletal related events resulting from metastases
12/15/2005WO2004096994A3 Genes upregulated in a tomato plant having an increased anthocyanin content phenotype
12/15/2005WO2004096989A9 Single chain antigen-binding polypeptides for polymer conjugation
12/15/2005WO2004067726A3 Isothermal reactions for the amplification of oligonucleotides
12/15/2005US20050277670 Chemokine receptor binding compounds
12/15/2005US20050277668 viricide, antiinflammatory agent; autoimmune diseases; protective effects against infection of target cells by a human immunodeficiency virus (HIV); 6-Chloro-N-((R)-3-{4-[(4-methoxy-phenyl)-(4-methyl-pyridin-3-ylmethyl)-amino]-piperidin-1-yl}-butyl)-2,4-dimethyl-nicotinamide
12/14/2005EP1605052A2 A method for producing influenza hemagglutinin multivalent vaccines
12/14/2005EP1605044A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
12/14/2005EP1604016A2 Generation of dendritic cells from monocytic dendritic precursor cells with gm-csf in the absence of additional cytokines
12/14/2005EP1604013A2 Aberrantly methylated genes in pancreatic cancer
12/14/2005EP1604012A2 METHODS AND COMPOSITIONS FOR SELECTIVE RNAi MEDIATED INHIBITION OF GENE EXPRESSION IN MAMMAL CELLS
12/14/2005EP1604009A2 Method for identifying risk of melanoma and treatments thereof
12/14/2005EP1603940A2 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv
12/14/2005EP1603585A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
12/14/2005EP1603406A2 Method for producing ethanol using raw starch
12/08/2005WO2005054432A3 Gene transfer for regulating smooth muscle tone
12/08/2005WO2005052126A3 Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (i) interferon producing cells
12/08/2005WO2005047471A3 Improved fret efficiency methods
12/08/2005WO2005047469A3 PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
12/08/2005WO2005023987A3 Cell-based assays for determining drug action
12/08/2005WO2005019410A3 Rnai agents for anti-sars coronavirus therapy
12/08/2005WO2005019408A3 Plants resistant to cytoplasm-feeding parasites
12/08/2005WO2005014779A9 Cyclodextrin affinity purification
12/08/2005US20050273267 Method for identifying markers
12/08/2005US20050272676 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/08/2005US20050271643 Bacterial strains, compositions including same and probiotic use thereof
12/07/2005EP1602724A1 Magnetic pigment
12/07/2005EP1601967A2 Identification of antigen epitopes
12/07/2005EP1601966A2 Methods and compositions for purification of nucleic acid from a host cell
12/07/2005EP1601795A2 Method for determining susceptibility of tumor to treatment with anti-neoplastic agent
12/07/2005EP1601784A2 Multiple controls for molecular genetic analyses
12/07/2005EP1601777A2 Methods to enhance the activity of lignocellulose-degrading enzymes
12/07/2005EP1601776A2 Expression vectors comprising the mcmv ie2 promoter
12/07/2005EP1601775A1 Animal model for the fast identification of pharmaceutical active compounds in vivo
12/07/2005EP1601767A2 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF EIF-5A1
12/07/2005EP1601765A2 Variants of enzymes of the alpha-amylase family
12/07/2005EP1601760A2 Nanopores, methods for using same, methods for making same and methods for characterizing biomolecules using same
12/07/2005EP1601757A2 Cell-polymer fiber compositions and use thereof
12/07/2005EP1601693A2 Novel compositions and methods for the treatment of immune related disease
12/07/2005EP1601642A2 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/07/2005EP1601373A2 Intracellular delivery of small molecules proteins and nucleic acids
12/07/2005CN1705740A Adenovirus expressing genes in reverse order and use thereof
12/07/2005CN1230539C Bacterial auto-inducer inactivation protein, its coded nucleic acid molecule and uses
12/07/2005CN1230536C Tie-2 ligands, methods of making and uses thereof
12/07/2005CN1230532C Human hybrid host cell for mammalian gene expression
12/01/2005WO2005112961A1 The use of a replication competent virus or its recombinant in therapy
12/01/2005WO2005091733A3 Traits in recombinant xylose-growing saccharomyces cerevisiae strains using genome-wide transcription analysis
12/01/2005WO2005047457B1 Polyisoprenyl benzophenones as inhibitors of histone acetyl transferases and uses thereof
12/01/2005WO2005005614A3 Combined b-cell and t-cell epitopes on vlp for improved vaccines
12/01/2005WO2005003305A3 Usps as modifiers of the beta catenin pathway and methods of use
12/01/2005WO2005001032A3 Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection
12/01/2005WO2004113497A3 Gene delivery to tumors
12/01/2005WO2004104175A3 Probiotic bacteria and methods
12/01/2005WO2004092343A3 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution
12/01/2005WO2004087875A3 Nucleic acid-associated proteins
12/01/2005WO2004072259A8 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof
12/01/2005WO2004070001A3 Assay and compositions for detection of bacillus anthracis nucleic acid
12/01/2005US20050267294 Antibodies with increased affinities for anthrax antigens
12/01/2005US20050266552 Reagents and methods for identification of RNAi pathway genes and chemical modulators of RNAi
12/01/2005US20050266417 Methods for identifying target nucleic acid molecules
12/01/2005US20050266400 Novel sequences encoding hepatitis C virus glycoproteins
12/01/2005US20050266397 Methods for identification of coronaviruses
11/2005
11/30/2005EP1599727A2 Method for producing an immobilised virus carrier and the use thereof
11/30/2005EP1599586A2 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth
11/30/2005EP1599578A2 Methods for preventing gluconoylation of proteins
11/30/2005EP1599577A2 Clinically relevant animal model of human breast cancer and vegf involvement in desmoplastic response, tamoxifen resistance and metastasis
11/30/2005EP1599576A2 Methods for selecting medications
11/30/2005EP1599573A2 Model for studying the role of genes in tumor resistance to chemotherapy
11/30/2005EP1599572A2 Compositions and methods for cancer immunotherapy
11/30/2005EP1599474A2 Alternative heterocycles for dna recognition
11/30/2005EP1599213A2 Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
11/30/2005CN1703521A Quantification of gene expression
11/30/2005CN1703238A Recombinant intracellular pathogen immunogenic compositions and methods for use
11/30/2005CN1229501C Mixture of recombinant vaccinia vectors as poly-envelope protein vaccines for HIV
11/29/2005US6969382 Method and apparatus for treating bodily tissues with medicinal substance
11/24/2005WO2005056770A3 Band 5: a human testis specific protein
11/24/2005WO2005052119A3 Adjuvants of immune response
11/24/2005WO2005049795A3 Mammalian cell lines for detecting, monitoring, and optimizing oligonucleotide-mediated chromosomal sequence alteration
11/24/2005WO2005044980A9 Zap protein and related compositions and methods
11/24/2005WO2005034871A3 Methods for treating diseases and conditions with inverse agonists
11/24/2005WO2004104177A3 Methods for localizing target molecules in a flowing fluid sample
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 100